Results 151 to 160 of about 9,172,312 (306)

An Algol Program to Solve the Linear Programming Problem

Operations Research ...
Powell, Bruce A. (Creatorcre)
core  

Analysis of the Exploratory Development Project Evaluation Experiment

Operations Research ...
Mathis, Samuel J., Jr. (Creatorcre), Svestka, Joseph (Creatorcre), Adler, Mauricio (Creatorcre), Lev, Benjamin (Creatorcre), Dean, Burton V. (Creatorcre)   +4 more
core  

An Analysis of a Method for Reducing Pretrial Delay in Court systems

Operations Research ...
Barrer, John N. (Creatorcre), Dean, Burton V. (Creatorcre)   +1 more
core  

An annotated bibliography on corporation R and D project evaluation and selection techniques

Operations Research ...
Dean, Burton V. (Creatorcre)
core  

Algorithms for Discounted Stachastic Games

Operations Research ...
Nair, K. P. K. (Creatorcre), Rao, S. Subba (Creatorcre), Chandrasekaran, R. (Creatorcre)   +2 more
core  

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Recurrent myocarditis masquerading as acute myocardial infarction: unmasking Behçet's disease. [PDF]

Oxf Med Case Reports
Atta M, Alqatati F, Alkhanafsa M, Jaber KR, Habib MB.   +4 more
europepmc   +1 more source

Analysis and Forecasting of Anesthesia Manpower in Cuyahoga County, Ohio

Operations Research ...
Reisman, A. (Creatorcre), Lewy, P. M. (Creatorcre), Kaujalgi, V. B. (Creatorcre), Esogbue, A. O. (Creatorcre), Dean, B. V. (Creatorcre), Aggarwal, V. V. (Creatorcre), Gravenstein, J. S. (Creatorcre)   +6 more
core  

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Application of Management Science Techniques to Dental Practice Management

Operations Research ...
Emmons, Hamilton (Creatorcre), Reisman, Arnold (Creatorcre), Rivaud, Juan (Creatorcre), Green, Edward J. (Creatorcre), Morito, Susumu (Creatorcre)   +4 more
core